Ysios Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Neurona is a clinical-stage biotherapeutics company developing allogeneic, off-the-shelf regenerative neural cell therapies that integrate into neural circuits to treat chronic neurological disorders.
BiotechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Executive Officer)Arnold Kriegstein(Director)
BoardPeter Svennilson(Director)inTim Kutzkey(Director)Ray Kelleher(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupAlexandriaFidelity InvestmentsLYFE Capital+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.